Article
Novartis AG v. Union of India & Others - Judgment
[full text of Supreme Court decision rejecting Novartis’ patent claim.]
Chronologie
-
To patent or not to patent? the case of Novartis’ cancer drug Glivec in India
Langues disponibles: English -
Patent wars: has India taken on Big Pharma and won?
Langues disponibles: English -
5 Take-Home Points From India’s Historic Novartis Patent Case
Langues disponibles: English -
Why Novartis case will help innovation [India]
Langues disponibles: English -
India’s Patently Wise Decision
Langues disponibles: English -
More battles in store [India]
Langues disponibles: English -
Finally, the patients prevail [India]
Langues disponibles: English -
Indian Supreme Court Delivers Verdict in Novartis Case
Langues disponibles: English -
The Novartis Saga: a timeline [India]
Langues disponibles: English -
Novartis AG v. Union of India & Others - Judgment
Langues disponibles: English -
Landmark verdict gives big boost to cancer patients [India]
Langues disponibles: English -
Supreme Court denial of Glivec patent clarifies limited intellectual property protection and discourages future innovation in India
Langues disponibles: English -
Analysis: Legal case in India threatens HIV drug access for poorest
Langues disponibles: English -
En Inde, l'accès aux génériques suspendu à un procès
-
Indian drugs boss hails Aids deal
Langues disponibles: English -
Novartis accusé de saper l’accès des pauvres aux médicaments [Inde]
-
World's poor still deprived of drugs - activists
Langues disponibles: English
Voir l’affaire judiciaire complète